Effectiveness of universal screening for vancomycin-resistant enterococcus and methicillin-resistant staphylococcus aureus on admission to a burn-trauma step-down unit

Journal of Burn Care and Research

Volumn 30, Issue 4, 2009, Pages 648-656

  Wibbenmeyer, Lucy ^a   Appelgate, Dianna ^b   Williams, Ingrid ^a   Light, Timothy ^a   Latenser, Barbara ^a   Lewis, Robert ^a   Kealey, Gerald Patrick ^a   Chen, Yiyi ^c   Onwuameze, Obiora ^a   Herwaldt, Loreen ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b Sacred Heart Medical Center Eugene   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; METICILLIN; VANCOMYCIN;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BURN UNIT; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE TRANSMISSION; FEMALE; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION PREVENTION; INFECTION RATE; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIOLOGY; SCREENING TEST; TREATMENT DURATION; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; BURN; CHI SQUARE DISTRIBUTION; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; EPIDEMIC; HETEROZYGOTE; INFECTION CONTROL; ISOLATION AND PURIFICATION; MASS SCREENING; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; NONPARAMETRIC TEST; PENICILLIN RESISTANCE; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS INFECTION;

ADULT; BURN UNITS; CARRIER STATE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROCOCCUS; FEMALE; HUMANS; INFECTION CONTROL; MALE; MASS SCREENING; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STATISTICS, NONPARAMETRIC; VANCOMYCIN RESISTANCE;

EID: 69249213756     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0b013e3181abff7e     Document Type: Article

References (44)

1. National Nosocomial Infections Surveillance (NNIS) System report data summary from January 1990 to May 1999, issued June 1999. Am J Infect Control 1999;27:520-532
2. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32: 470-485
3. Bhavnani SM, Drake JA, Forrest A, et al. A nationwide, mul-ticenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible en-terococcal bacteremia. Diagn Microbiol Infect Dis 2000;36: 145-158
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-59
5. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592-598
6. Vergis EN, Hayden MK, Chow JW, et al. Determinants of vancomycin resistance and mortality rates in enterococcal bacteremia. A prospective multicenter study. Ann Intern Med 2001;135:484-492
7. Falk PS, Winnike J, Woodmansee C, Desai M, Mayhall CG. Outbreak of vancomycin-resistant enterococci in a burn unit. Infect Control Hosp Epidemiol 2000;21:575-582
8. Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of active surveillance cultures and contact/ droplet precautions for control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2002;51:126-132
9. Lucet JC, Armand-Lefevre L, Laurichesse JJ, et al. Rapid control of an outbreak of vancomycin-resistant enterococci in a French university hospital. J Hosp Infect 2007;67:42-48
10. Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee (HICPAC). Infect Control Hosp Epidemiol 1995;16:105-113
11. Garner JS. Guideline for isolation precautions in hospitals. Part I. Evolution of isolation practices, Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996;24:24-31.
12. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:362-386
13. Nijssen S, Bonten MJ, Weinstein RA. Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis 2005;40:405-409
14. Sunenshine RH, Liedtke LA, Fridkin SK, Strausbaugh LJ. Management of inpatients colonized or infected with antimicrobial-resistant bacteria in hospitals in the United States. Infect Control Hosp Epidemiol 2005;26:138-143
15. Girou E, Pujade G, Legrand P, Cizeau F, Brun-Buisson C. Selective screening of carriers for control of methicillin-resistant Staphylococcus aureus (MRSA) in high-risk hospital areas with a high level of endemic MRSA. Clin Infect Dis 1998;27:543-550
16. Huang SS, Yokoe DS, Hinrichsen VL, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clin Infect Dis 2006;43:971-978
17. Muto CA, Giannetta ET, Durbin LJ, Simonton BM, Farr BM. Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant enterococcus. Infect Control Hosp Epidemiol 2002;23:429-435
18. Cohen SH, Morita MM, Bradford M. A seven-year experience with methicillin-resistant Staphylococcus aureus. Am J Med 1991;91:233S-7.
19. Saint S, Higgins LA, Nallamothu BK, Chenoweth C. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003;31: 354-356
20. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003;290:1899-1905
21. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003;36:281-285
22. Huang SS, Rifas-Shiman SL, Pottinger JM, et al. Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis 2007;195:339-346
23. Huang SS, Rifas-Shiman SL, Warren DK, et al. Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007;195:330-338
24. Lucet JC, Chevret S, Durand-Zaleski I, Chastang C, Regnier B. Prevalence and risk factors for carriage of methicillin-resistant Staphylococcus aureus at admission to the intensive care unit: results of a multicenter study. Arch Intern Med 2003;163:181-188
25. Warren DK, Guth RM, Coopersmith CM, Merz LR, Zack JE, Fraser VJ. Epidemiology of methicillin-resistant Staphylococcus aureus colonization in a surgical intensive care unit. Infect Control Hosp Epidemiol 2006;27:1032-1040
26. Bonten MJ, Kullberg BJ, van Dalen R, et al. Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. J Antimicrob Che-mother 2000;46:351-362
27. Lucet JC, Paoletti X, Lolom I, et al. Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005;31: 1051-1057
28. Lai KK, Kelley AL, Melvin ZS, Belliveau PP, Fontecchio SA. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions. Infect Control Hosp Epidemiol 1998;19:647-652
29. Cepeda JA, Whitehouse T, Cooper B, et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005;365:295-304.
30. Furuno JP, Harris AD, Wright MO, et al. Prediction rules to identify patients with methicillin-resistant Staphylococcus au-reus and vancomycin-resistant enterococci upon hospital admission. Am J Infect Control 2004;32:436-440
31. Tacconelli E, Karchmer AW, Yokoe D, D'Agata EM. Preventing the influx of vancomycin-resistant enterococci into health care institutions, by use of a simple validated prediction rule. Clin Infect Dis 2004;39:964-970
32. Warren DK, Kollef MH, Seiler SM, Fridkin SK, Fraser VJ. The epidemiology of vancomycin-resistant enterococcus colonization in a medical intensive care unit. Infect Control Hosp Epidemiol 2003;24:257-263
33. Haley CC, Mittal D, Laviolette A, Jannapureddy S, Parvez N, Haley RW. Methicillin-resistant Staphylococcus aureus infection or colonization present at hospital admission: multivari-able risk factor screening to increase efficiency of surveillance culturing. J Clin Microbiol 2007;45:3031-3038
34. Diekema DJ, BootsMiller BJ, Vaughn TE, et al. Antimicrobial resistance trends and outbreak frequency in United States hospitals. Clin Infect Dis 2004;38:78-85.
35. Polgreen PM, Beekmann SE, Chen YY, et al. Epidemiology of methicillin-resistant Staphylococcus aureus and vancomy-cin-resistant enterococcus in a rural state. Infect Control Hosp Epidemiol 2006;27:252-256
36. Furuno JP, McGregor JC, Harris AD, et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 2006;166:580-585
37. Girou E, Azar J, Wolkenstein P, Cizeau F, Brun-Buisson C, Roujeau JC. Comparison of systematic versus selective screening for methicillin-resistant Staphylococcus aureus carriage in a high-risk dermatology ward. Infect Control Hosp Epidemiol 2000;21:583-587
38. Jernigan JA, Pullen AL, Flowers L, Bell M, Jarvis WR. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol 2003;24:409-414
39. Lee TA, Hacek DM, Stroupe KT, Collins SM, Peterson LR. Three surveillance strategies for vancomycin-resistant entero-cocci in hospitalized patients: detection of colonization efficiency and a cost-effectiveness model. Infect Control Hosp Epidemiol 2005;26:39-46.
40. Murray BE. Vancomycin-resistant enterococcal infections. N Engl J Med 2000;342:710-721
41. Safdar N, Maki DG. The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida. Ann Intern Med 2002;136:834-844
42. Papia G, Louie M, Tralla A, Johnson C, Collins V, Simor AE. Screening high-risk patients for methicillin-resistant Staphylococcus aureus on admission to the hospital: is it cost effective? Infect Control Hosp Epidemiol 1999;20:473-477
43. Coello R, Jimenez J, Garcia M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994;13:74-81.
44. Montecalvo MA, Jarvis WR, Uman J, et al. Infection-control measures reduce transmission of vancomycin-resistant entero-cocci in an endemic setting. Ann Intern Med 1999;131: 269-272